GENEA BIOMEDX
LIVE

Serial Number

79168866

Owner

Genea IP Holdings Pty Ltd

Attorney

Eric Lamb

Filing Date

Apr 30, 2015

Add to watchlist:

No watchlists yet
View on USPTO

GENEA BIOMEDX Trademark

Serial Number: 79168866 • Registration: 5093258

GENEA BIOMEDX is a trademark filed by Genea IP Holdings Pty Ltd on April 30, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Genea IP Holdings Pty Ltd (15 trademarks)

L2,

Entity Type: 98

Genea Biomedx Pty Ltd

L2 321 Kent St

Entity Type: 99

Trademark Details

Filing Date

April 30, 2015

Registration Date

December 6, 2016

Published for Opposition

September 20, 2016

Goods & Services

human cell products, namely, pluripotent and differentiated human cells and stem cells for medical purposes and clinical use, bioassays and cell culture media for use in medical applications; biological and chemical products and substances for medical use, namely, biological and chemical preparations to support growth of human cells and embryos, cell culture media for medical or clinical use, chemical reagents for medical or clinical use; preparations for the diagnosis of pregnancy; preparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproduction

Surgical and medical apparatus and instruments for use in general surgical or medical procedures; surgical and medical equipment in the nature of incubators and parts and fittings therefor for in vitro fertilization or treatment of infertility and other disorders relating to fertility and human reproduction; surgical and medical equipment in the nature of apparatus, instruments and equipment for vitrification, cultivation, cryopreservation, warming and thawing of human blastocysts, human reproductive tissue, human sperm, human oocytes or human embryos and parts and fittings therefor for surgical or medical purposes; surgical and medical equipment in the nature of equipment for identifying, separating, extracting and processing human sperm or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for monitoring the development, cultivation or cryopreservation of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for surgical or medical purposes; surgical and medical equipment in the nature of equipment for storing or preserving human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes and being for surgical or medical purposes

[ Scientific and technological services, namely, scientific research, the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; scientific research and design services in the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; providing information about scientific research in the fields of reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, the development of culture media and media formulations, media evaluation, embryo storage, cell cloning, fertility testing; laboratory services, namely, medical laboratories, clinical laboratories and scientific research laboratories in the field of development of culture media and media formulations; providing information in the fields of medical laboratories, clinical laboratories and scientific research laboratories relating to reproductive science, human fertility, human reproduction, human genetics, stem cells, assisted conception, reproductive genetics, in vitro fertilisation, fertility management, embryology, andrology, embryo biopsy, genetic diagnosis, immunology, endocrinology, ultrasonology, media evaluation, embryo storage, cell cloning, fertility testing, the development of culture media and media formulations ]

Scientific and laboratory apparatus, instruments and equipment, namely, incubators and parts and fittings therefor used to support development of human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, apparatus, instruments and equipment and parts and fittings therefor for vitrification, cultivation, cryopreservation, warming and thawing of human blastocysts, human reproductive tissue, human sperm, human oocytes or human embryos, all being for scientific or laboratory use; scientific and laboratory apparatus instruments and equipment, namely, equipment for identifying, separating, extracting and processing human sperm or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for monitoring the development, cultivation, cryopreservation, warming or thawing of human, embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use; scientific and laboratory apparatus, instruments and equipment, namely, equipment for storing or preserving human embryos, human reproductive tissue, human sperm, human blastocysts or human oocytes, all being for scientific or laboratory use

[ Retail and wholesale store services featuring human cell products, bioassays and cell culture media for use in medical or medical research applications, biological and chemical products and substances for medical use, preparations for the diagnosis of pregnancy, preparations for the diagnosis and/or treatment of infertility and other disorders relating to fertility and human reproduction, scientific apparatus, scientific instruments, scientific equipment, laboratory apparatus, laboratory instruments, laboratory equipment, surgical apparatus, surgical instruments, surgical equipment, medical apparatus, medical instruments, medical equipment, educational materials and programs for use by medical, research or scientific laboratories, clinics and facilities, medical practitioners, doctors, clinicians, hospitals and medical patients ]

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Dec 6, 2025 REM4
INTERNATIONAL REGISTRATION RENEWED
May 29, 2025 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Nov 8, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 9, 2024 INPS
INVALIDATION PROCESSED
Oct 9, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 1, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jan 31, 2024 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Jan 31, 2024 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 29, 2024 APRE
TEAS SECTION 71 RECEIVED
May 24, 2023 ES71
NEW REPRESENTATIVE AT IB RECEIVED
Jan 7, 2022 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 6, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 15, 2019 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 18, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 18, 2019 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 1, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 10, 2017 FICS
FINAL DISPOSITION PROCESSED
Mar 10, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 6, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2016 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 2, 2016 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 20, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 20, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 31, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 31, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 31, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 8, 2016 ERFR
CHANGE OF OWNER RECEIVED FROM IB
Jun 16, 2016 CHLD
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 24, 2016 GNFN
FINAL REFUSAL E-MAILED
Feb 24, 2016 GNFR
FINAL REFUSAL WRITTEN
Feb 24, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2016 TEME
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 19, 2016 TCCA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2016 TROA
REFUSAL PROCESSED BY IB
Sep 4, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 20, 2015 RFCS
REFUSAL PROCESSED BY MPU
Aug 20, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 19, 2015 RFCR
NON-FINAL ACTION WRITTEN
Aug 18, 2015 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 21, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 16, 2015 REPR